Focusing in on COPD
SNG001 – currently in Phase II clinical trial
LOXL2 programme (being progressed by Pharmaxis)
– Phase I clinical trials complete
Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.